Aevo vs Bio Protocol — how do they compare? Aevo trades at Rp343.47 (market cap Rp321,32M, Rp55,12M 24h volume), while Bio Protocol trades at Rp444.34 (market cap Rp1,01T, Rp168,57M 24h volume). The key difference: Bio Protocol is far larger — about 3143.3× Aevo's market cap, and Aevo's circulating supply is 932,6M / 1B AEVO (94%) versus 2,3B / 3,3B BIO (69%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Aevo for 89 Days and Bio Protocol for 18 Days on average.
| AEVO | BIO | |
|---|---|---|
Market Cap | Rp321,32M | Rp1,01T |
Volume (24h) | Rp55,12M | Rp168,57M |
Circulating Supply | 932,6M / 1B AEVO (94%) | 2,3B / 3,3B BIO (69%) |
Typical Hold Time | 89 Days | 18 Days |
What Pluang investors did over the last 30 days
Aevo is the world's first high-performance decentralized options exchange. The exchange runs on a custom EVM roll-up that rolls up to Ethereum. Aevo operates an off-chain orderbook with on-chain settlements. This means that once orders are matched, trades get executed and settled with smart contracts.
Read more on AEVO →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →